✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Wockhardt Ltd.

WOCKPHARMA

Market Cap
₹23,837 Cr.
P/E
0.00

Wockhardt Ltd.

  • Wockhardt
  • Astrazeneca Pharma I
  • Gland Pharma
  • TJI Pharma - Small Cap
FAQs on Wockhardt Ltd. Shareprice

Wockhardt has given better returns compared to its competitors.
Wockhardt has grown at ~32.09% over the last 4yrs while peers have grown at a median rate of -0.96%

Wockhardt is not expensive.
Latest PE of Wockhardt is 0.0, while 3 year average PE is 1.21.
Also latest EV/EBITDA of Wockhardt is 110 while 3yr average is 152.

View FAQ's On Business
Growth Table
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Balance Sheet
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Cash Flow
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Quarterly Results
  • Wockhardt Ltd.
  • Astrazeneca Pharma I
  • Gland Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Wockhardt Ltd. Financials

Balance sheet of Wockhardt is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Wockhardt is increasing.
Latest debt of Wockhardt is ₹1,979 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹1,054 Crs.

Yes, profit is increasing.
The profit of Wockhardt is -₹189 Crs for TTM, -₹463 Crs for Mar 2024 and -₹559 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Wockhardt latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech